logo

For the Inventor, By the Inventor

Waban, MA, United States of America

Catherine R O'Riordan

This inventor holds 19 USPTO granted patents and 6 published patent applications and 6 EPO patents, primarily in Gene Therapy. Top assignees: Genzyme Corporation, Other. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine R O'Riordan. Retrieved from https://idiyas.com/inventor/catherine-r-o-riordan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 85(Granted Patents)


Location History:

  • Boston, MA (US) (1999 - 2001)
  • Jamaica Plain, MA (US) (2003)
  • Westborough, MA (US) (2018)
  • Waban, MA (US) (2017 - 2023)
  • Bridgewater, NJ (US) (2019 - 2023)

Company Filing History:

goldMedal18 out of 825 
 
Genzyme Corporation
 patents
silverMedal1 out of 834,570 
Other
 patents

Years Active: 1999-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Gene Therapy
RNAi
Viral Particles
AAV Detection
Spinal Muscular Atrophy
Cystic Fibrosis
Recombinant Viruses
Nucleic Acid Delivery
Amyotrophic Lateral Sclerosis
Retinitis Pigmentosa
Analytical Ultracentrifugation
Rod-Derived Cone Viability Factor
19 patents (USPTO):Explore Patents
1. 12123880 - Methods for detecting AAV (2024-10-22),
2. 11698377 - Methods for detecting AAV (2023-07-11),
3. 11639887 - Analytical ultracentrifugation for characterization of recombinant viral particles (2023-05-02),
4. 11603529 - Variant RNAi (2023-03-14),
5. 11554161 - Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders (2023-01-17),
6. 11103598 - Gene therapy for retinitis pigmentosa (2021-08-31),
7. 10920245 - Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders (2021-02-16),
8. 10821154 - Compositions and methods for treating spinal muscular atrophy (2020-11-03),
9. 10760079 - Variant RNAi (2020-09-01),
10. 10744210 - Gene therapy for spinal cord disorders (2020-08-18),
11. 10450563 - Variant RNAi (2019-10-22),
12. 10429288 - Analytical ultracentrifugation for characterization of recombinant viral particles (2019-10-01),
13. 10383953 - Gene therapy for retinitis pigmentosa (2019-08-20),
14. 10035829 - Methods to produce rod-derived cone viability factor (RDCVF) (2018-07-31),
15. 9890394 - Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders (2018-02-13),

Title: The Innovative Mind of Catherine R O'Riordan

Introduction: Catherine R O'Riordan is a pioneering inventor based in Waban, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Catherine R O'Riordan's latest patents include cutting-edge technologies in the healthcare sector, sustainable energy solutions, and advanced materials science.

Career Highlights: With a career spanning over two decades, Catherine R O'Riordan has established herself as a leading figure in the world of innovation. Her work has been recognized with numerous awards and accolades.

Collaborations: Throughout her career, Catherine R O'Riordan has collaborated with top research institutions, universities, and companies to bring her inventions to life. Her collaborative spirit has led to the development of impactful technologies.

Conclusion: Catherine R O'Riordan's passion for innovation and dedication to pushing the boundaries of what is possible make her a true trailblazer in the world of inventors. Her work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…